Frontlight ResearchEarly access
Trial site
L'institut de cardiologie de Montreal
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Amyloidosis1 trial
- Coronary artery disease1 trial
- Phase
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Eidos Therapeutics, a BridgeBio company1 trial
- Ottawa Hospital Research Institute1 trial
Running trials
Active, not recruiting
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
Active, not recruiting
The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial
Site data: ClinicalTrials.govUpdated 12 Nov 2026